Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Bormann (Hannover, Germany), R. Maus (Hannover, Germany), J. Stolper (Hannover, Germany), C. Brandenberger (Hannover, Germany), T. Welte (Hannover, Germany), J. Gauldie (Hamilton, Canada), M. Kolb (Hamilton, Canada), U. Maus (Hannover, Germany). Late Breaking Abstract - Role of matrix metalloproteinase-2 and -9 in experimental lung fibrosis in mice. 4243

Member's Comments

No comment yet.

Related content which might interest you: Expression of elastolytic matrix metalloproteinases in bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002 Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Temporal and spatial distribution of matrix metalloproteinases in bleomycin-induced fibrosis rats Source: Eur Respir J 2001; 18: Suppl. 33, 80s Year: 2001 Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Matrix metalloproteinase-2 is protective in bleomycin-induced pulmonary fibrosis Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Lung overexpression of matrix metalloproteinase-2 protects against bronchial asthma Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Matrix metalloproteinases in pulmonary fibrosis Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis Year: 2013 The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002 Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004 Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007 Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Source: Eur Respir J 2008; 32: 644-650 Year: 2008 Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Source: Eur Respir J 2002; 20: 170-176 Year: 2002 Late Breaking Abstract - Matrix metalloproteinases in serum and sputum reflect distinct processes of relevance to asthma Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury Source: Eur Respir J 2001; 18: 827-837 Year: 2001 Metalloproteinases in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 38: 1461-1467 Year: 2011